Astellas Pharma

Astellas, founded in 2005, stands at the forefront of the pharmaceutical industry with a focus on improving the health of people around the world through innovative and reliable healthcare solutions. The company is headquartered in Tokyo, Japan, and continues to grow its global presence with a dedicated workforce of over 14,754 employees. Under the leadership of CEO Naoki Okamura, Astellas is committed to delivering significant advances in patient care through cutting-edge technologies and research.

The company specialises in the development of pharmaceuticals and biotechnology products, aiming to address unmet medical needs and provide effective treatments for patients. Astellas invests heavily in research and development, ensuring that its pipeline is robust with promising therapies that have the potential to transform lives. By leveraging scientific innovation and collaboration, Astellas is dedicated to enhancing patient outcomes and contributing positively to global health.

Astellas' mission extends beyond drug development; it encompasses a holistic approach to healthcare, integrating patient care and support services into its offerings. The company seeks to build partnerships and collaborations that foster innovation and bring new therapies to market efficiently. As a leader in the pharmaceutical sector, Astellas continues to uphold its commitment to quality, safety, and ethical standards, making a meaningful impact in the field of medicine.